Libby Baney Discusses DRUGS Act Momentum With World Trademark Review

Government and regulatory affairs partner Libby Baney spoke to World Trademark Review about how the Domain Reform for Unlawful Drug Sellers (DRUGS) Act has been introduced in the U.S. Senate and House. The publication explained that the new bill is designed to ensure that social media platforms and websites are held accountable for failing to prevent the sale of dangerous illegal drugs on their platforms. 

Baney, who is also senior advisor to the Alliance for Safe Online Pharmacies (ASOP Global), said, “Today, consumers are going online to buy medicine and other products more than ever before. Criminals know this and use domain names to feign legitimate pharmacy operations, taking advantage of patients’ desire for medication access and cost savings. We can and must do more to protect patient safety online. The introduction of the DRUGS Act is a critical step toward a safer internet for all patients. ASOP Global will work tirelessly to see this bill signed into law.”

The full article is available for World Trademark Review subscribers.